Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Elands

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
FEBS Letters|March 14, 1988
125I-d(CH2)5[Tyr(Me)2, Tyr(NH2)9]AVP: iodination and binding characteristics of a vasopressin receptor ligandJ Elands, C Barberis, S Jard, et al.
Pharmacology, Biochemistry, and Behavior|February 1, 1995
Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrinN Seiler, C Grauffel, J Elands, et al.
European Journal of Pharmacology|March 1, 1988
125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligandJ Elands, C Barberis, S Jard, et al.
The Journal of Biological Chemistry|October 27, 1995
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regionsB Mouillac, B Chini, M N Balestre, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor familyB Chini, B Mouillac, Y Ala, et al.
The EMBO Journal|May 15, 1995
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptorB Chini, B Mouillac, Y Ala, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Identification of agonist binding sites of vasopressin and oxytocin receptorsB Mouillac, B Chini, M N Balestre, et al.
European Journal of Pharmacology|January 24, 1998
The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraineM A Petty, J Elands, M P Johnson, et al.
International Journal of Cancer|September 26, 2018
Associations of adult-attained height and early life energy restriction with postmenopausal breast cancer risk according to estrogen and progesterone receptor statusRachel J J Elands, Nadine S M Offermans, Colinda C J M Simons, et al.
Plos One|September 20, 2016
A Systematic Literature Review and Meta-Regression Analysis on Early-Life Energy Restriction and Cancer Risk in HumansRachel J J Elands, Colinda C J M Simons, Martien van Dongen, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
FEBS Letters|March 14, 1988
125I-d(CH2)5[Tyr(Me)2, Tyr(NH2)9]AVP: iodination and binding characteristics of a vasopressin receptor ligandJ Elands, C Barberis, S Jard, et al.
Pharmacology, Biochemistry, and Behavior|February 1, 1995
Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrinN Seiler, C Grauffel, J Elands, et al.
European Journal of Pharmacology|March 1, 1988
125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligandJ Elands, C Barberis, S Jard, et al.
The Journal of Biological Chemistry|October 27, 1995
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regionsB Mouillac, B Chini, M N Balestre, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor familyB Chini, B Mouillac, Y Ala, et al.
The EMBO Journal|May 15, 1995
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptorB Chini, B Mouillac, Y Ala, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Identification of agonist binding sites of vasopressin and oxytocin receptorsB Mouillac, B Chini, M N Balestre, et al.
European Journal of Pharmacology|January 24, 1998
The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraineM A Petty, J Elands, M P Johnson, et al.
International Journal of Cancer|September 26, 2018
Associations of adult-attained height and early life energy restriction with postmenopausal breast cancer risk according to estrogen and progesterone receptor statusRachel J J Elands, Nadine S M Offermans, Colinda C J M Simons, et al.
Plos One|September 20, 2016
A Systematic Literature Review and Meta-Regression Analysis on Early-Life Energy Restriction and Cancer Risk in HumansRachel J J Elands, Colinda C J M Simons, Martien van Dongen, et al.
Pageof 3